Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

CCDC26 Polymorphisms Are Differentially Expressed in Myeloid Malignancies with Mutant IDH1 Compared to Their IDH2 R140-Mutated or IDH -Unmutated Counterparts

Terra L Lasho, MT, (ASCP), Ayalew Tefferi, MD, Animesh Pardanani, MBBS, PhD, Christy Finke, BS, Stephanie R Fink, Paul A Decker, Robert Jenkins

Blood (2011) 118 (21): 2807.

https://doi.org/10.1182/blood.V118.21.2807.2807

Published: 2011

Journal Articles

Syk Tyrosine Kinase Is Overexpressed in the Majority of Peripheral T- and NK-Cell Lymphomas, and Represents a Potential Therapeutic Target.

Andrew L. Feldman, MD, David X. Sun, PhD, Mark E. Law, BS, Anne J. Novak, PhD, Ayoma D. Attygalle, MD, Erik C. Thorland, PhD, Stephanie R. Fink, BA, Julie A. Vrana, PhD, B. Lynn Caron, William G. Morice, MD, PhD, Ellen D. Remstein, MD, Karen L. Grogg, MD, Paul J. Kurtin, MD, William R. Macon, MD, Ahmet Dogan, MD, PhD

Blood (2007) 110 (11): 690.

https://doi.org/10.1182/blood.V110.11.690.690

Published: 2007

Journal Articles

Frequency, Hematopathology and Detection of a New Isodicentric Variant of Deletion 20q.

Stephanie R. Fink, Stephanie A. Smoley, Sarah F. Paternoster, Kimberly J. Stockero, Lai P. Nguyen, Phuong L. Nguyen, M.D., Curtis A. Hanson, M.D., Gordon W. Dewald, Ph.D.

Blood (2006) 108 (11): 4843.

https://doi.org/10.1182/blood.V108.11.4843.4843

Published: 2006

Journal Articles

A Phase I Trial of Autologous Dendritic Cell Therapy for Chronic Myelogenous Leukemia.

Mark Robert Litzow, M.D., Allan B. Dietz, Ph.D., Peggy A. Bulur, Greg W. Butler, Stephanie R. Fink, Louis Letendre, M.D., Sarah F. Paternoster, Ayalew Tefferi, M.D., Antje Hoering, Ph.D., Stanimir Vuk-Pavlovic, Ph.D.

Blood (2004) 104 (11): 2931.

https://doi.org/10.1182/blood.V104.11.2931.2931

Published: 2004

Journal Articles

Interphase Fluorescence In Situ Hybridization (FISH) with an IgH Probe Is Important in the Management of Patients with a Clinical Diagnosis of Chronic Lymphocytic Leukemia (CLL).

Grzegorz S. Nowakowski, MD, Gordon W. Dewald, PhD, Sarah F. Paternoster, Stephanie R. Fink, Stephanie A. Smoley, Ellen D. Remstein, MD, James D. Hoyer, MD, Robert L. Phyliky, MD, Timothy G. Call, MD, Tait D. Shanafelt, MD, Clive S. Zent, MD

Blood (2004) 104 (11): 1919.

https://doi.org/10.1182/blood.V104.11.1919.1919

Published: 2004

NARROW

CCDC26 Polymorphisms Are Differentially Expressed in Myeloid Malignancies with Mutant IDH1 Compared to Their IDH2 R140-Mutated or IDH -Unmutated Counterparts

Syk Tyrosine Kinase Is Overexpressed in the Majority of Peripheral T- and NK-Cell Lymphomas, and Represents a Potential Therapeutic Target.

Frequency, Hematopathology and Detection of a New Isodicentric Variant of Deletion 20q.

A Phase I Trial of Autologous Dendritic Cell Therapy for Chronic Myelogenous Leukemia.

Interphase Fluorescence In Situ Hybridization (FISH) with an IgH Probe Is Important in the Management of Patients with a Clinical Diagnosis of Chronic Lymphocytic Leukemia (CLL).

Email alerts

ASH Publications

American Society of Hematology

CCDC26 Polymorphisms Are Differentially Expressed in Myeloid Malignancies with Mutant IDH1 Compared to Their IDH2 R140-Mutated or IDH -Unmutated Counterparts

Syk Tyrosine Kinase Is Overexpressed in the Majority of Peripheral T- and NK-Cell Lymphomas, and Represents a Potential Therapeutic Target.

Frequency, Hematopathology and Detection of a New Isodicentric Variant of Deletion 20q.

A Phase I Trial of Autologous Dendritic Cell Therapy for Chronic Myelogenous Leukemia.

Interphase Fluorescence In Situ Hybridization (FISH) with an IgH Probe Is Important in the Management of Patients with a Clinical Diagnosis of Chronic Lymphocytic Leukemia (CLL).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only